{
    "pmcid": "8201996",
    "qa_pairs": {
        "How do nanobodies neutralize SARS-CoV-2 according to the paper?": [
            "Nanobodies neutralize SARS-CoV-2 by directly blocking the receptor-binding domain (RBD) of the spike protein, preventing its interaction with the human ACE2 receptor.",
            "Nanobodies neutralize SARS-CoV-2 by enhancing the immune response through cytokine release.",
            "Nanobodies neutralize SARS-CoV-2 by degrading viral RNA inside infected cells.",
            "Nanobodies neutralize SARS-CoV-2 by inhibiting viral replication through protease inhibition."
        ],
        "What are nanobodies, and from which species are they derived?": [
            "Nanobodies are single-domain antibodies derived from camelid species like llamas and alpacas.",
            "Nanobodies are double-domain antibodies derived from bovine species like cows and buffaloes.",
            "Nanobodies are single-domain antibodies derived from rodent species like mice and rats.",
            "Nanobodies are multi-domain antibodies derived from avian species like chickens and ducks."
        ],
        "What are some challenges mentioned in the development and application of nanobodies?": [
            "Challenges include ensuring sufficient neutralization potency and avoiding the development of escape mutants.",
            "Challenges include the high cost of production and limited availability of camelid species.",
            "Challenges include the inability to bind to the spike protein and low stability in vivo.",
            "Challenges include the requirement for complex purification processes and low yield in production."
        ],
        "What technology is used for the rapid screening and isolation of potent nanobody binders against specific viral targets?": [
            "Phage display technology is used for the rapid screening and isolation of potent nanobody binders.",
            "CRISPR-Cas9 technology is used for the rapid screening and isolation of potent nanobody binders.",
            "RNA interference technology is used for the rapid screening and isolation of potent nanobody binders.",
            "Mass spectrometry technology is used for the rapid screening and isolation of potent nanobody binders."
        ],
        "Which nanobody is mentioned as having cross-reactivity with both SARS-CoV and SARS-CoV-2?": [
            "VHH-72 is mentioned as having cross-reactivity with both SARS-CoV and SARS-CoV-2.",
            "VHH-58 is mentioned as having cross-reactivity with both SARS-CoV and SARS-CoV-2.",
            "VHH-90 is mentioned as having cross-reactivity with both SARS-CoV and SARS-CoV-2.",
            "VHH-35 is mentioned as having cross-reactivity with both SARS-CoV and SARS-CoV-2."
        ]
    }
}